New Dietary Ingredient Notification Draft Guidance Must Be Withdrawn – CRN and CHPA
This article was originally published in The Tan Sheet
You may also be interested in...
Supplement Firms Making Drug Claims Land On Fast Track To Notoriety At FDA
FDA is compiling an ongoing list of “online advisory letters” to identify supplement firms that fail to respond within 30 days to notices about noncompliant claims. The agency anticipates spurring an uptick in NDI notifications by publishing a draft guidance by the end of the year.
Supplement Firms Making Drug Claims Land On Fast Track To Notoriety At FDA
FDA is compiling an ongoing list of “online advisory letters” to identify supplement firms that fail to respond within 30 days to notices about noncompliant claims. The agency anticipates spurring an uptick in NDI notifications by publishing a draft guidance by the end of the year.
Reps Threaten Legislation To Align NDI Guidance With DSHEA
The letter from the office of caucus co-chair Rep. Burton says the House members contacted FDA following the agency’s “dismissal” of a Senate request to withdraw or revise the NDI draft guidance. Rep. Ron Paul, a candidate for the GOP nomination for president, also signed the letter.